Yury Gubarev

Dr. Yury Gubarev

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Macroheterocycles
Verified
Journal Article
Closed access
Oscar I. KoifmanOscar I. Koifman
Oscar I. Koifman
TATatyana A. Ageeva
Tatyana A. Ageeva
Irina Petrovna  BeletskayaIrina Petrovna Beletskaya
Irina Petrovna Beletskaya
AAAlexei D. Averin
Alexei D. Averin
AYAlexei A. Yakushev
Alexei A. Yakushev
EYElena S. Yurina
Elena S. Yurina

23 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
NLNatalia Lebedeva
Natalia Lebedeva
YGYury Gubarev
Yury Gubarev
MKMikhail Koifman
Mikhail Koifman
Oscar I. KoifmanOscar I. Koifman
Oscar I. Koifman
The problem of treating viral infections is extremely relevant due to both the emergence of new viral diseases and to the low effectiveness of existing approaches to the treatment of known viral infections. This review focuses on the application of porphyrin, chlorin, and phthalocyanine series for combating viral infections by chemical and photochemical inactivation methods. The purpose of this review paper is to summarize the main approaches developed to date in the chemical and photodynamic inactivation of human and animal viruses using porphyrins and their analogues and to analyze and discuss the information on viral targets and antiviral activity of porphyrins, chlorins, of their conjugates with organic/inorganic compounds obtained in the last 10–15 years in order to identify the most promising areas.

1 June 2018 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
NLNatalya Sh. Lebedeva
Natalya Sh. Lebedeva
EYElena S. Yurina
Elena S. Yurina
YGYury Gubarev
Yury Gubarev
SSSergey A. Syrbu
Sergey A. Syrbu

30 September 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NLNatalia Sh. Lebedeva
Natalia Sh. Lebedeva
YGYury Gubarev
Yury Gubarev
GMGalina M. Mamardashvili
Galina M. Mamardashvili
SZSvetlana V. Zaitceva
Svetlana V. Zaitceva
SZSergey A. Zdanovich
Sergey A. Zdanovich
OKOskar I. Koifman
Oskar I. Koifman
The pandemic infectious disease (Covid-19) caused by the coronavirus (SARS-CoV2) is spreading rapidly around the world. Covid-19 does an irreparable harm to the health and life of people. It also has a negative financial impact on the economies of most countries of the world. In this regard, the issue of creating drugs aimed at combating this disease is especially acute. In this work, molecular docking was used to study the docking of 23 compounds with QRF3a SARS-CoV2. The performed in silico modeling made it possible to identify leading compounds capable of exerting a potential inhibitory and virucidal effect. The leading compounds include chlorin (a drug used in PDT), iron(III)protoporphyrin (endogenous porphyrin), and tetraanthraquinone porphyrazine (an exogenous substance). Having taken into consideration the localization of ligands in the QRF3a SARS-CoV2, we have made an assumption about their influence on the pathogenesis of Covid-19. The interaction of chlorin, iron(III)protoporphyrin and protoporphyrin with the viral protein ORF3a were studied by fluorescence and UV–Vis spectroscopy. The obtained experimental results confirm the data of molecular docking. The results showed that a viral protein binds to endogenous porphyrins and chlorins, moreover, chlorin is a competitive ligand for endogenous porphyrins. Chlorin should be considered as a promising drug for repurposing.

1 February 2018 in Journal of Photochemistry and Photobiology A: Chemistry
Verified
Journal Article
Closed access
NLNatalia Lebedeva
Natalia Lebedeva
EYElena S. Yurina
Elena S. Yurina
YGYury Gubarev
Yury Gubarev
ALAlexey V. Lyubimtsev
Alexey V. Lyubimtsev
SSSergey A. Syrbu
Sergey A. Syrbu

1 September 2018 in Journal of Molecular Liquids
Verified
Journal Article
Closed access
NLNatalia Lebedeva
Natalia Lebedeva
YGYury Gubarev
Yury Gubarev
EYElena S. Yurina
Elena S. Yurina
SSSergey A. Syrbu
Sergey A. Syrbu